Chemotherapy and Sequential Immunotherapy for Locally Advanced Urothelial Cancer

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(4 sites)

Netherlands

Radboud UMC, Nijmegen, Gelderland

Jeroen Bosch ziekenhuis, 's-Hertogenbosch, North Brabant

Amphia ziekenhuis, Breda, North Brabant

Erasmus MC, Rotterdam, South Holland